JIR
ENZN

James Investment Research’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

James Investment Research’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-45,115
Closed -$44K – 508
2015
Q3 		$44K Buy
45,115
+26,475
+142% +$32.6K ﹤0.01% 350
2015
Q2 		$22K Hold
18,640
– – ﹤0.01% 427
2015
Q1 		$20K Buy
+18,640
New +$19.3K ﹤0.01% 449

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.42B AUM 22.12% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

James Investment Research's ENZN Position: Q4 2015 in Review

James Investment Research sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q4 2015, closing a stake of 45,115 shares — an estimated $44K sold.

James Investment Research first reported a position in ENZN in Q1 2015 and held it in 3 quarters. The position peaked at $44K in Q3 2015. 49 funds tracked by Wall St. Rank hold ENZN as of Q4 2015.

  • James Investment Research reported no remaining ENZON PHARMACEUTICALS INC position as of Q4 2015 after selling out during the quarter.
  • James Investment Research sold 45,115 ENZON PHARMACEUTICALS INC shares in Q4 2015, an estimated $44K.
  • James Investment Research first reported a position in ENZON PHARMACEUTICALS INC in Q1 2015 and held it in 3 quarters.
  • James Investment Research's ENZON PHARMACEUTICALS INC position peaked at $44K in Q3 2015.
  • 49 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q4 2015.

Based on James Investment Research's 13F filing for Q4 2015, filed 27 Jan 2016.